Related Experiment Video
Updated: Mar 14, 2026

06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.9K
Is It Possible to Delay or Prevent Age-Related Cognitive Decline?
1Academic Geriatric Department, Geneva University, Geneva, Switzerland.
Korean Journal of Family Medicine
|October 1, 2016
Summary
Preventing dementia is a public health priority. Identifying modifiable risk factors and multimodal interventions offers hope for delaying cognitive decline and Alzheimer
Area of Science:
- Neuroscience
- Public Health
- Gerontology
Background:
- Dementia, including Alzheimer's disease, affects millions globally, with projections indicating a significant increase in prevalence.
- The World Health Organization and Alzheimer's Disease International recognize cognitive decline prevention as a critical public health priority.
- Despite decades of research, successful dementia drug discovery remains elusive, highlighting the need for alternative strategies.
Purpose of the Study:
- To review identified risk factors for dementia and evaluate the effectiveness of interventions aimed at prevention or delay.
- To assess the impact of modifiable lifestyle factors on cognitive decline.
- To analyze the results of randomized controlled trials (RCTs) for dementia prevention strategies.
Main Methods:
- Analysis of numerous longitudinal studies and meta-analyses to identify dementia risk and protective factors.
- Review of randomized controlled trials (RCTs) evaluating single lifestyle interventions and multimodal interventions.
- Examination of interventions targeting beta-amyloid compounds.
Main Results:
- Ninety-three risk factors for dementia have been identified, with seven major modifiable factors including low education, sedentary lifestyle, midlife obesity, smoking, hypertension, diabetes, and depression.
- Additional modifiable risk factors include midlife hypercholesterolemia, late-life atrial fibrillation, and chronic kidney disease.
- While single lifestyle interventions showed promise in observational studies, RCTs before 2014 yielded negative results; however, recent multimodal intervention RCTs show increased optimism.
Conclusions:
- Modifiable risk factors present a target for dementia prevention strategies.
- Multimodal interventions demonstrate potential for delaying cognitive decline and preventing dementia.
- Further research into interventions, including those targeting beta-amyloid, is ongoing.
More Related Videos
Related Concept Videos
Cognitive Development During Adulthood
1.1K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
793
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
793
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Dementia
656
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
656
Aging
945
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
945

